Mycopreneur
Dillan DiNardo: Mindstate Design Labs
May 17, 2024
Dillan DiNardo, Co-Founder of Mindstate Design Labs, discusses exploring altered states of consciousness for mental health, the intersection of FDA regulation and decentralized psychedelic use, preparing for the distribution of psychedelic therapy, exploring novel psychedelics and shifting consciousness, and future plans of Mindstate Design Labs.
55:37
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Exploration of diverse viewpoints is crucial in advancing psychedelic research.
- Tailored therapeutic outcomes can be achieved through intentionally designing altered states of consciousness.
Deep dives
Discussion on Dichotomy in Psychedelic Space
The podcast episode explores the dichotomy in the psychedelic space between advocates for widespread and decentralized use versus a more medical paradigm. The discussion highlights the importance of listening to divergent viewpoints and the essential role of both FDA-approved models and decriminalization approaches in advancing psychedelic research.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
